| For: | Georgiadou S, Gatselis NK, Stefos A, Zachou K, Makaritsis K, Rigopoulou EI, Dalekos GN. Efficient management of secondary haemophagocytic lymphohistiocytosis with intravenous steroids and γ-immunoglobulin infusions. World J Clin Cases 2019; 7(21): 3394-3406 [PMID: 31750324 DOI: 10.12998/wjcc.v7.i21.3394] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v7/i21/3394.htm |
| Number | Citing Articles |
| 1 |
Mahdi M Fadlallah, Sarah M Salman, Mariam M Fadlallah, Hassan Rahal. Hemophagocytic Syndrome and COVID-19: A Comprehensive Review. Cureus 2023; doi: 10.7759/cureus.36140
|
| 2 |
Aashi Gupta, Bimlesh Prasad, Ajit Dhumale, Kundavaram Rajkumar, Vikrant S Bhar, Shruti Gupta. Navigating a Dual Hyperinflammatory State: Overlap of Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) and Secondary Hemophagocytic Lymphohistiocytosis (HLH) in a Child. Cureus 2026; doi: 10.7759/cureus.100848
|
| 3 |
Kawser Ahmed, Ashfaq Hamid. Recognizing Haemophagocytic Lymphohistiocytosis in an HIV Patient With Disseminated Tuberculosis: Not Every Fever is Sepsis. Cureus 2025; doi: 10.7759/cureus.94772
|
| 4 |
Yajing Zhao, Jianjian Zhang, Jianling Qiao, Chuanfang Liu, Xinguang Liu. A Patient With Three Types of Hematologic Disorders and Hemophagocytic Lymphohistiocytosis Triggered by SARS-CoV-2: A Case Report. Cureus 2025; doi: 10.7759/cureus.87754
|
| 5 |
Touba Bougiouklou, Vasileios Petrakis, Ioulia Dragoumani, Evanthia Gouveri, Dimitrios Papazoglou. Case Reports of Visceral Leishmaniasis-Associated Hemophagocytic Lymphohistiocytosis in Adults: A Complex Immune Phenomenon. Reports 2026; 9(1): 29 doi: 10.3390/reports9010029
|
| 6 |
George N. Dalekos, Aggelos Stefos, Sarah Georgiadou, Vasiliki Lygoura, Anastasia Michail, George Ntaios, Anna Samakidou, George Giannoulis, Stella Gabeta, Marianna Vlychou, Efthymia Petinaki, Konstantinos Leventogiannis, Evangelos J. Giamarellos-Bourboulis, Nikolaos K. Gatselis. Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19. European Journal of Internal Medicine 2021; 88: 52 doi: 10.1016/j.ejim.2021.03.026
|
| 7 |
Smitha Hosahalli Vasanna, Jignesh Dalal. Traffic jam within lymphocytes: A clinician’s perspective. Frontiers in Immunology 2023; 13 doi: 10.3389/fimmu.2022.1034317
|
| 8 |
Xue Wang, Yingying Zhao, Yanfei Han, Yongbo Zhang. Neurological Involvement in Adult‐Onset Secondary Hemophagocytic Lymphohistiocytosis: Clinical Features and Prognostic Implications. Brain and Behavior 2026; 16(2) doi: 10.1002/brb3.71228
|
| 9 |
Eibhlin Goggins, Behdad Afzali, Mark D. Okusa. Chronic granulomatous disease with suspected secondary hemophagocytic lymphohistiocytosis: a case report and hypothesis-generating rationale for neuroimmune modulation. Critical Care 2026; doi: 10.1186/s13054-026-05945-7
|
| 10 |
Pakkiyaretnam Mayurathan. Dengue Hemorrhagic Fever Causing Postpartum Hemorrhage and Hemophagocytic Lymphohistiocytosis in a Young Woman: A Case Report. Cureus 2024; doi: 10.7759/cureus.53841
|
| 11 |
Harish Kasarabada, Zubair Akhtar, Usha Devaraju. Fulminant Neisseria septicemia with secondary hemophagocytic lymphohistiocytosis. American Journal of Pharmacotherapy and Pharmaceutical Sciences 2025; 4: 7 doi: 10.25259/AJPPS_2025_007
|
| 12 |
Dominique D. Davis, Saffett Guleryuz, Yehuda Galili, Pablo A. Bejarano, Dawei Cui. Secondary Dengue Infection Complicated by Hemophagocytic Lymphohistiocytosis: A Case Report. Case Reports in Infectious Diseases 2025; 2025(1) doi: 10.1155/crdi/9208878
|
| 13 |
Kalliopi Azariadis, Maria Ioannou, Kalliopi Zachou, George N. Dalekos, Larry M. Bush. An Immunocompetent HIV-Negative Elderly Patient with Low-Grade Fever, Generalized Lymphadenopathy, Splenomegaly, and Acute Phase Response: Do Not Forget Castleman Disease. Case Reports in Infectious Diseases 2021; 2021: 1 doi: 10.1155/2021/6614208
|
| 14 |
Sumin Jo, Hye Lim Jung, Sooyeon Lim, Eun Sil Kim, Aram Yang, Ji Hee Kwak, Deok Soo Kim, Jung Yeon Shim, Jae Won Shim. Case of Chronic Active Epstein-Barr Virus Infection Developed Hemophagocytic Lymphohistiocytosis after COVID-19 Infection. Clinical Pediatric Hematology-Oncology 2023; 30(2): 80 doi: 10.15264/cpho.2023.30.2.80
|
| 15 |
Wei-Lun Lan, Chih-Hao Chen, Yuan-Chia Chu, Yen-Fu Cheng, Chii-Yuan Huang. Is There an Association between Concurrent Epstein–Barr Virus Infection and Sudden Hearing Loss?—A Case—Control Study in an East Asian Population. Journal of Clinical Medicine 2023; 12(5): 1946 doi: 10.3390/jcm12051946
|
| 16 |
Matthew J. Riley, Scott R. Hicks, Sharon Irvine, Tom J. Blanchard, Edward Britton, Howida Shawki, Muhammad Sajid Pervaiz, Tom E. Fletcher. Hereditary haemochromatosis, haemophagocytic lymphohistiocytosis and COVID-19. Clinical Infection in Practice 2020; : 100052 doi: 10.1016/j.clinpr.2020.100052
|
| 17 |
Akira Shibata, Michihiro Ono, Shutaro Oiwa, Atsushi Uesugi, Seiya Saito, Makoto Usami, Tomoyuki Abe, Masahiro Yoshida, Masahiro Maeda, Kohichi Takada. Successful Management of Suspected Epstein–Barr Virus‐Associated Hemophagocytic Lymphohistiocytosis in BRAF‐Mutant Cholangiocarcinoma Following Treatment With Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors: A Case Report. Cancer Reports 2026; 9(3) doi: 10.1002/cnr2.70504
|
| 18 |
Antonios A. Koutalos, Alexandros Koskiniotis, Christos Rountas, Efstathios Konstantinou, Sarah Georgiadou, Aggelos Stefos, Nikolaos K. Gatselis, George N. Dalekos, Konstantinos N. Malizos. Osteonecrosis risk after steroids-related treatment of COVID-19 is not negligible: A cross sectional study. European Journal of Internal Medicine 2024; 123: 127 doi: 10.1016/j.ejim.2024.01.006
|
